Bacterial and fungal infections in persons who inject drugs
Clinical Microbiology Reviews · 11.09.2025 · 38 (3)
DOI: 10.1128/cmr.00162-23 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 11.09.2025. Verfasst von Jeffrey Masters und 11 weiteren Autor:innen. Beteiligte Einrichtung: Kirby Institute UNSW, Kensington, New South Wales, Australia. Hauptthemen laut MEDLINE: Mycoses, Substance Abuse, Intravenous, Bacterial Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 387 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Persons who inject drugs are at increased risk of bacterial and fungal injecting-related infections due to many physiological, societal, and structural factors. An estimated 15 million persons inject drugs worldwide, with recent increases in the burden of injecting-related infections. Acquisition of these infections has distinct pathophysiology and microbiology related to drug supply, drug composition, and the process of injecting. Clinical management of these infections is complicated by usual factors such as the need for source control and effective antibiotics, as well as the complex challenges faced by persons who inject drugs while in hospital. These challenges include drug withdrawal, difficult pain control related to opioid tolerance, stigma, discrimination, and lack of access to outpatient parenteral antibiotic therapy, which can lead to high rates of patient-directed discharge and non-completion of treatment with subsequent poor outcomes. This review seeks to provide an evidence-based summary of what is known about the risks, epidemiology, microbiology, and presentation of injecting-related bacterial and fungal infections, as well as provide recommendations for treatment, including pharmacological considerations, opportunistic screening, multidisciplinary team care, and approaches to outpatient therapy. It also provides insight into the medicolegal and ethical considerations of care for persons who inject drugs and a first-person perspective of someone with lived experience.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Kirby Institute UNSW, Kensington, New South Wales, Australia.
- Department of Infectious Diseases, Royal Prince Alfred Hospital, Sydney, Australia.
- Washington University in St Louis School of Medicine, St. Louis, Missouri, USA.
- Department of Medicine, Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
- School of Law, Deakin University, Melbourne, Victoria, Australia.
- School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.
ORCID-Profile: Jeffrey Masters, Erin McCreary, Joshua S Davis, Steven Y C Tong, Gregory J Dore
Förderung
- National Health and Medical Research Council
Zitieren
APA
Masters, J., Goodman-Meza, D., Russell, D., Marks, L., McCreary, E., Jacka, B., Seear, K., Davis, J. S., Matthews, G., Martinello, M., Tong, S. Y. C., & Dore, G. J. (2025). Bacterial and fungal infections in persons who inject drugs. Clinical Microbiology Reviews, 38(3). https://doi.org/10.1128/cmr.00162-23
Vancouver
Masters J, Goodman-Meza D, Russell D, Marks L, McCreary E, Jacka B, et al. Bacterial and fungal infections in persons who inject drugs. Clinical Microbiology Reviews. 2025;38(3). doi:10.1128/cmr.00162-23
BibTeX
@article{Masters2025,
author = {Masters, Jeffrey and Goodman-Meza, David and Russell, Danielle and Marks, Laura and McCreary, Erin and Jacka, Brendan and Seear, Kate and Davis, Joshua S and Matthews, Gail and Martinello, Marianne and Tong, Steven Y C and Dore, Gregory J},
title = {Bacterial and fungal infections in persons who inject drugs},
journal = {Clinical Microbiology Reviews},
year = {2025},
volume = {38},
number = {3},
doi = {10.1128/cmr.00162-23}
}
EUVIMED